Selman Abraham Waksman is credited with developing streptomycin, the first antibiotic to treat tuberculosis. Waksman's sole credit is controversial, however, because Albert Schatz, one of Waksman's graduate students at Rutgers University, was considered a co-discoverer of the drug.
Selman Abraham Waksman is credited for developing streptomycin, the first antibiotic to treat tuberculosis. Waksman's sole credit is contentious, however, because Albert Schatz, one of Waksman's graduate students at Rutgers University, was considered <a href="https://www.acs.org/content/acs/en/education/whatischemistry/landmarks/selmanwaksman.html" target="_blank" target="_blank">a co-discoverer of the drug</a>.     